Simulated effect of gentamicin assay errors on calculated pharmacokinetic values

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Computational Biology

Background:

• Accurate measurement of drug concentrations is crucial for effective therapeutic drug monitoring.
• Gentamicin therapy requires careful monitoring of peak (Cmax) and trough (Cmin) concentrations to ensure efficacy and minimize toxicity.
• Computer simulations offer a valuable tool for assessing the impact of measurement errors in pharmacokinetic studies.

Purpose of the Study:

• To evaluate the impact of systematic errors in gentamicin concentration measurements on pharmacokinetic calculations and subsequent dosing regimens.
• To determine how varying magnitudes and types of errors (in Cmax, Cmin, or both) influence the accuracy of gentamicin dosing.
• To identify factors that exacerbate the effects of measurement errors in gentamicin therapy.

Main Methods:

• Computer simulations were employed to model gentamicin pharmacokinetics in four virtual patients across three dosing schemes.
• Systematic errors, ranging from -80% to +80%, were introduced into simulated Cmax and Cmin values.
• Pharmacokinetic parameters were recalculated based on error-containing concentrations, and new dosing regimens were derived to achieve target concentrations.

Main Results:

• Increasing absolute error in measured concentrations generally led to larger absolute resultant errors and deviations from desired Cmax and Cmin values.
• Errors were more pronounced with negative induced errors, errors affecting Cmax, and shorter dosing intervals.
• Resultant errors in pharmacokinetic variables exceeded induced errors even at +/- 5% induced error levels.
• Toxic or suboptimal gentamicin concentrations were infrequent with induced errors between -20% and +20%.

Conclusions:

• Assay errors in serum gentamicin concentration measurements can significantly amplify resultant errors, particularly with increasing error magnitude, underreporting, or impact on peak concentrations.
• Shorter dosing intervals increase the susceptibility of gentamicin therapy to assay errors.
• Careful consideration of potential measurement errors and their impact on pharmacokinetic calculations is essential for optimizing gentamicin dosing strategies.